Neuromodulation for the treatment of urological conditions including overactive bladder symptoms has been available for decades but minimal advances have been made to improve efficacy, decrease cost and decrease morbidity. In the past few years, however, many novel devices that take advantage of new technologies have been developed and are currently in testing phases. These new devices address current limitations by using wireless battery charging, external power source technology and minimally invasive percutaneous implantation techniques. In addition to innovative devices, neuromodulation is also expanding for use for broader patient indications and targeting novel nerve targets including the dorsal genital and cavernous nerves.
